1-4 of 4
Stephen Yu
Close
Sort by
Journal Articles

The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Christopher Rushton, BSc, Miguel Alcaide, PhD, Matthew Cheung, BSc, Neil R Michaud, Scott Daigle, Ryan N Rys, BSc, BA, Sarah E Arthur, BSc, Marquisa Zrymiak, BSc, Jordan Davidson, BSc, Kevin R Bushell, BSc, MSc, Stephen Yu, MSc, Michael D. Jain, MDPhD, Lois E. Shepherd, Marco A. Marra, PhD, John Kuruvilla, MD, Michael Crump, MD, Koren Kathleen Mann, PhD, Sarit E Assouline, MD MSc, Joseph M. Connors, MD, Christian Steidl, MD, Nathalie A Johnson, MD PhD, David W. Scott, MBChB, PhD, Ryan D Morin, PhDBSc,MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-142871
Published: 2020
Journal Articles

Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP

Christopher Rushton, BSc, Sarah E Arthur, BSc, Miguel Alcaide, PhD, Matthew Cheung, BSc, Nicole Thomas, BSc, Laura K Hilton, PhD, Neil R Michaud, Scott Daigle, Jordan Davidson, BSc, Kevin R Bushell, BSc, MSc, Stephen Yu, MSc, Michael D. Jain, MD PhD, Lois E. Shepherd, Michael Crump, MD FRCPC, Koren Kathleen Mann, PhD, John Kuruvilla, MD, Sarit Assouline, MD, Kirstie Cleary, PhD, Mark S Cragg, Prof, David W. Scott, MBChB, PhD, Nathalie Johnson, MD, Ryan D. Morin, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 921.
https://doi.org/10.1182/blood-2019-127399
Published: 2019
Journal Articles

Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma

Che-Leung Law, BSc,PhD, Wade Aaron, Rick Austin, Manasi Barath, Evan Callihan, Thomas Evans, Maria Gamez Guerrero, Golzar Hemmati, Adrie Jones, Kathryn Kwant, Llewelyn Lao, Bryan Lemon, Katrine Moldt, Purbasa Patnaik, Kenneth Sexton, Holger Wesche, Yinghua Xiao, Stephen Yu, Tim Yu
Journal: Blood
Blood (2018) 132 (Supplement 1): 3225.
https://doi.org/10.1182/blood-2018-99-113921
Published: 2018
Journal Articles

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

Clinical Trials & Observations
Sarit E. Assouline, Torsten Holm Nielsen, Stephen Yu, Miguel Alcaide, Lauren Chong, David MacDonald, Axel Tosikyan, Vishal Kukreti, Abbas Kezouh, Tina Petrogiannis-Haliotis, Marco Albuquerque, Daniel Fornika, Sepideh Alamouti, Remi Froment, Celia M. T. Greenwood, Kathleen Klein Oros, Errol Camglioglu, Ayushi Sharma, Rosa Christodoulopoulos, Caroline Rousseau, Nathalie Johnson, Michael Crump, Ryan D. Morin, Koren K. Mann
Journal: Blood
Blood (2016) 128 (2): 185–194.
https://doi.org/10.1182/blood-2016-02-699520
Published: 2016
Includes: Supplemental data